Late Stage Pharma Lifecycle Management

By attending this course, you will:

	1	Understand product maturity and be prepared for what happens at patent expiry
	2	Know which drivers of differentiation can be used in a seemingly undifferentiated world
	3	Learn where, when and how to compete in a generic world using pricing and contracting strategies, authorized and own generic strategies, Rx to OTC switching strategies, etc.
	4	Learn how to select the best tactics for your brand(s)
	5	Be able to take portfolio management decisions at late stage
	6	Know how to build winning organizations in late stage LCM
	7	Gain insights from real world LCM case studies and benefit from Neal’s insightful recommendations based on his unique background as a senior consultant in working on LCM solutions for many pharma companies.

 

What sets the Late Stage Pharma Lifecycle Management course apart?

The expert: Not only is Dr. Neal Hansen highly knowledgeable about pharma LCM, he is also a talented speaker – very lively and passionate about this subject. He has worked globally with senior executive levels in the pharma industry across therapeutic areas, but he is also very knowledgeable about realities in the national markets.

The content: Dr. Neal Hansen and his consulting team have gained unparalleled expertise through the numerous consulting assignments they have performed for the pharma industry in the area of LCM. The reason is simple: Datamonitor Healthcare's consulting team can capitalize on years of research and analysis on this topic conducted by their analysts. But Neal enriches his course with insightful recommendations he has drawn from working on pharma LCM solutions, in a format that fosters interaction and learning.

Who should attend?

Brand Managers and their managers, as well as managers in related planning and intelligence functions dealing with mature brands.

Executives from professional services organizations should request approval from Neal Hansen prior to registering to this course. Please contact Tanya Petroffa, Office Assistant, Tanya.petroffa@celforpharma.com; tel +32(0)27092107).

Past participants

Below is a non-exhaustive list of executives who participated in the Optimizing Brand Lifecycle Management Strategies course, which was Neal Hansen’s LCM course up to end 2011:

Project Manager	Abbott	Ireland
New Products Manager	Almirall	Spain
Senior Manager Strategic Planning	Amgen	Switzerland
Senior Brand Director	Astellas	UK	testimonial
Senior Director of European Marketing	Astellas	UK
Global Brand Manager	AstraZeneca	UK	testimonial
Senior Product Manager	AstraZeneca	Romania
Project & Portfolio Manager - Renal Europe	Baxter	Belgium
Global Brand Manager	Bayer Schering Pharma	Germany
Commercial Manager	Esteve	Spain
Head of Business Development	GlaxoSmithKline	Germany
Senior Vice President	Grünenthal	Germany	testimonial
Head of Global Brands - Life Cycle Management	Grünenthal	Germany	testimonial
Sn. Manager, Product Management; Commercial Operations	Helsinn	Switzerland	testimonial
Global Brand Manager	Intendis	Germany
VP Portfolio Management	Ipsen	France
Director Strategic Planning	Janssen-Cilag	France
Vice President Marketing	Kowa Pharmaceuticals	UK
International Brand Manager	Lundbeck	Denmark
Head of LCM Department	Merck Santé	France	testimonial
Executive Director R&D Operations	Merz	Germany
LCM Director	Novartis	Switzerland	testimonial
International Product Manager	Novo Nordisk	Denmark	testimonial
Managing Director - Dermatology & Cosmetics	Pierre Fabre	Germany
Senior International Medical Leader a.i.	Roche	Switzerland
Medical Affairs Manager	Schering Plough	Belgium
International Marketing Director	Servier	France
Marketing Manager	Solvay	Romania	testimonial
Global Product Director Cardiology	Solvay	Switzerland
Senior Director RA Global Medical Affairs Immunology	UCB	Belgium	testimonial
Marketing Manager CNS	UCB	Belgium

Programme outline of the Late Stage Pharma Lifecycle Management course

You are welcome to join us for the welcome coffee at 09:30h. The actual programme starts at 10:00h and closing will be no later than 17:00h. 

Understanding Product Maturity – What Happens at Patent Expiry?

What defines product maturity? Market forces shaping the landscape for late stage LCM What happens at patent expiry – exploring the world … Generic company strategies – what are their goals? Defining success in late stage LCM – what are our goals?

Differentiating in an Undifferentiated World

Drivers of differentiation in a mature world Clinical differentiation – what is still possible? Focus on unmet needs – what can we do? Non clinical differentiation – how do we make a brand bigger than a molecule?

Commercial Success – Where, When and How to Compete in a Generic World

Understanding the drivers of competition in a generic world Where and when to compete – segmenting the world Pricing and contracting strategies Authorised and own generic strategies Rx to OTC switching

Breakout Exercise – Selecting The Best Tactics

Exploration of potential tactical approaches to late stage LCM Case study-based prioritisation and planning

Portfolio Management at Late Stage – Shaping Success in Established Brands

Managing a mature brands portfolio – what to keep and what to drop? To withdraw or not – discontinue, divest or de-prioritise? Building a portfolio – expansion strategies to drive growth Portfolio-based LCM prioritisation – acting in the best interest of the whole…

Organising for Success – What Drives Winning Behaviour in Late Stage LCM

Organisational must haves – building success Structuring for success – lessons from the industry Planning for success – what makes a good LCM plan From plan to action – realising success for your brands

Final Discussion & Closing

Learning methodology

In addition to his very effective interactive lecturing technique, Neal uses numerous industry cases to illustrate and discuss the LCM strategies taught during the theoretical sessions.

Meet the expert: Dr. Neal Hansen

Neal is the Global Director of Datamonitor’s Healthcare Consulting Practice. In this role, he leads a multi-disciplinary team focusing on the provision of customized solutions to leading players in the pharmaceutical and biotechnology industries in key areas such as portfolio and brand management, in- and out-licensing and forecasting.

Prior to this role, Neal was the European Head of Consulting within Wood Mackenzie’s Life Sciences Practice. During his time at Wood Mackenzie, Neal led commercial assessment, scenario planning and war gaming projects for numerous top tier and mid-cap pharmaceutical companies in Europe, the US and Japan. Earlier in his career, Neal held various senior roles within Datamonitor including Lead Consultant and Lead Analyst for Strategic and Company Intelligence encompassing Strategic Insight, eHealthInsight and PharmaVitae Company Tracking.

He has authored in-depth analyses on strategic issues affecting the pharmaceutical industry, focusing on lifecycle management, pharmaceutical sales force strategies, competitive dynamics in mature and emerging markets and the changing nature of the global generics sector. He has chaired and spoken at numerous conferences in the field of lifecycle management and the changing nature of the generics industry. His work has featured in In Vivo, The Economist, The Wall Street Journal, MedAd News and PharmaFocus.

Neal holds a PhD in Pharmacology (University of Cambridge), and a MA in Natural Sciences (University of Cambridge).

Dates

• 19 April 2012, Brussels
• 20 November 2012, Brussels

Interested in additional dates?
Leave your email address to be kept informed:

Venue & Accommodation

19 April 2012, Brussels
20 November 2012, Brussels

These courses take place at the Sheraton Airport Hotel & Conference Center which is situated opposite Brussels National Airport, literally at 2 minutes' walking distance from the arrival hall.

Sheraton Brussels Airport Hotel
Brussels National Airport
1930 Zaventem
Belgium
Tel: +32 (0) 2 710 80 00
Fax: +32 (0) 2 710 80 80

We have secured preferential room rates at this four-star hotel for our delegates. Registering three weeks or more prior to the course will secure your room at a preferential rate. Upon your registration, C.E.L.forpharma will send you a Sheraton Brussels Airport Hotel Accommodation Sheet to complete and send back.
Do not hesitate to contact Tanya Petroffa, Office Assistant, if you need assistance in this matter. (Tanya.petroffa@celforpharma.com; tel +32(0)27092107)

Registration fee

19 April 2012 Course, Brussels (LCM-11)		Price(*)
Registration before 2 March 2012		€1.270
Registration after 2 March 2012		€1.470

20 November 2012 Course, Brussels (LCM-12)		Price(*)
Registration before 5 October 2012		€1.270
Registration after 5 October 2012		€1.470

* (VAT excl.)

Group discounts are offered as of 3 or more registrations from the same company.
Do not hesitate to contact Tanya Petroffa, Office Assistant (Tanya.petroffa@celforpharma.com; tel +32(0)27092107) for more information.

To register, please go to our online registration form.

Testimonials of the Late Stage Pharma Lifecycle Management course

Below are testimonials from past participants of the Optimizing Brand Lifecycle Management Strategies course, which was Neal Hansen’s LCM course up to end 2011:

"An excellent comprehensive overview of LCM strategies. Neal Hansen's experience is very strong, enabling him to illustrate his points with recent and relevant case studies."

Susan Wood, Senior Brand Director, Astellas – UK

"The way Neal brought the key points to life with numerous real examples from many different therapy areas and lifecycle stages was really helpful"

Francesca Drake, Global Brand Manager, AstraZeneca - UK

"This course is an excellent opportunity to learn about the rationale of LCM, its aspects and how to apply it. Great opportunity as well to discuss specific problems with the excellent trainer Neal Hansen and the course participants."

Killian Duffner, Senior Vice President, Grünenthal - Germany

"Neal was not only able to give us a broad and structured overview of all LCM options, he could also always refer to concrete examples from his experience to illustrate the point. This made for a very lively course I would recommend to attend."

Philippe Ghem, Head of Global Brands - Life Cycle Management, Grünenthal - Germany

“Neal Hansen’s LCM seminar provided lots of food for thought. He enriched the theory with some excellent examples throughout the course of where you can add real value to a Brand in a competitive environment at any point in its life. Very informative and well led by Neal!”

Kevin Palmer, European Marketing Manager - Analgesics, Mundipharma International - UK

"I am truly impressed by the breadth and depth of Neal’s knowledge, as well as by the variety of “real life” examples he discussed during the course"

Iulia Radau, Business Development Director, AstraZeneca – Romania

"A highly useful course!"

Troels Sorensen, Senior Director RA, Global Medical Affairs Immunology, UCB – Belgium

"A very good job in giving a 1-day high quality overview! Good idea to extend it to 2 days next time to discuss more actual examples and include case study group work"

Marc Bouiller, Lifecycle Management Strategy Leader, Novartis - Switzerland

"The Optimizing Brand Lifecycle Management Strategies course gave me a complete view about LCM, needed for a better understanding of the changing environment."

Ionut Taranu, Marketing Manager, Solvay – Romania

"I did not waste my time! I picked up two-three hints to apply in my job."

Massimo Tosi, Senior Manager Product Management and Commercial Operations, Helsinn – Switzerland

"The seminar gave me a very useful overview of a number of lifecycle management strategies - and I particularly enjoyed Dr. Tijana Ignjatovic's overview of the current situation within bio-similars as well as the interesting discussions amongst the participants."

Kirsten Walter, International Product Manager, Novo Nordisk - Denmark

"The LCM course was really great for me as I worked both on the generics and originators side. My career will definitely benefit from the many ideas and expertise shared at this course."

Korhan Firat, Product Manager, Sandoz - Turkiye

"The 'Pharma Lifecyle Management Seminar' fulfilled all my expectations by providing a very accurate analysis of all possible strategic options to be envisaged for any drug product. In particular, presentations held by Dr. Neal Hansen and Dr. Tony Ellery, based on real cases, addressed key issues and provided pertinent solutions to be potentially envisaged for future LCM projects."

Eric Teillaud, Head of LCM department, Merck Santé - France

"Valuable seminar, for anyone interested in understanding the current and future LCM strategies/trends. Also a great opportunity to interact, build relationship and share information with other LCM stakeholders from other industries. Recommended."

Louis Andre Villeneuve, International Product Manager, Novo Nordisk - Denmark

"An excellent opportunity to learn and discuss about best practices and the future trends of one of the most challenging topics for the Pharmaceutical Industry nowadays."

Mercedes Diz, New Products Manager, Almirall - Spain

"I found the seminar very useful due to its small size and interactive workshop quality"

Marion Bock, (Former) Regional Commercial Affairs Director, Astellas Pharma Europe - Germany

Tips & Insights from Neal Hansen

• Be cautious when considering a Fixed Dose Combination!
• Do you know how to prepare for a ‘best practice’ optimization of your brand’s lifecycle management strategies?
• Do you know the 3 major categories of lifecycle management strategies?

 

(Go to top of the Late Stage Pharma Lifecycle Management course page)